These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9758555)

  • 1. [Alzheimer disease. Irreversible AChE inhibition with metrifonate].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1998 Aug; 21(8):250. PubMed ID: 9758555
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating response to metrifonate.
    Tariot PN
    J Clin Psychiatry; 1998; 59 Suppl 9():33-7. PubMed ID: 9720485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metrifonate: overview of safety and efficacy.
    Cummings JL
    Pharmacotherapy; 1998; 18(2 Pt 2):43-6; discussion 79-82. PubMed ID: 9543464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metrifonate: update on a new antidementia agent.
    Ringman JM; Cummings JL
    J Clin Psychiatry; 1999 Nov; 60(11):776-82. PubMed ID: 10584768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?
    Sandson TA
    Neurology; 1999 Feb; 52(3):675-6. PubMed ID: 10025821
    [No Abstract]   [Full Text] [Related]  

  • 6. Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?
    Knopman DS
    Neurology; 1998 May; 50(5):1203-5. PubMed ID: 9595961
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice.
    Liu L; Ikonen S; Heikkinen T; Tapiola T; van Groen T; Tanila H
    Exp Neurol; 2002 Feb; 173(2):196-204. PubMed ID: 11822883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metrifonate. A viewpoint.
    Taylor P
    Drugs Aging; 1997 Dec; 11(6):497. PubMed ID: 9413708
    [No Abstract]   [Full Text] [Related]  

  • 9. Preclinical pharmacology of metrifonate.
    Jann MW
    Pharmacotherapy; 1998; 18(2 Pt 2):55-67; discussion 79-82. PubMed ID: 9543466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating Alzheimer's disease with cholinergic drugs, Part 2.
    Terpstra T; Terpstra T
    Nurse Pract; 1999 Jan; 24(1):117-9. PubMed ID: 9950002
    [No Abstract]   [Full Text] [Related]  

  • 11. Metrifonate. A viewpoint.
    Giacobini E
    Drugs Aging; 1997 Dec; 11(6):497. PubMed ID: 9413707
    [No Abstract]   [Full Text] [Related]  

  • 12. New drug treatment for Alzheimer's disease. Treatment with metrifonate warrants multicentre trials.
    Zamar AC; Wise ME; Watson JP
    BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841012
    [No Abstract]   [Full Text] [Related]  

  • 13. Metrifonate for Alzheimer's disease patients.
    Schneider LS
    J Clin Psychiatry; 2000 Mar; 61(3):218-9. PubMed ID: 10817111
    [No Abstract]   [Full Text] [Related]  

  • 14. Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease.
    Kaufer D
    Dement Geriatr Cogn Disord; 1998; 9 Suppl 2():8-14. PubMed ID: 9718229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacological basis for metrifonate's favourable tolerability in the treatment of Alzheimer's disease.
    Schmidt BH; Heinig R
    Dement Geriatr Cogn Disord; 1998; 9 Suppl 2():15-9. PubMed ID: 9718230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The recovery of cerebrospinal fluid acetylcholinesterase activity in Alzheimer's disease patients after treatment with metrifonate.
    Unni L; Vicari S; Moriearty P; Schaefer F; Becker R
    Methods Find Exp Clin Pharmacol; 2000; 22(1):57-61. PubMed ID: 10791297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metrifonate on cognitive decline in Alzheimer disease: a double-blind, placebo-controlled, 6-month study.
    Becker RE; Colliver JA; Markwell SJ; Moriearty PL; Unni LK; Vicari S
    Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):54-7. PubMed ID: 9539412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metrifonate: a new agent for the treatment of Alzheimer's disease.
    Williams BR
    Am J Health Syst Pharm; 1999 Mar; 56(5):427-32. PubMed ID: 10096702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seizures in patients receiving concomitant antimuscarinics and acetylcholinesterase inhibitor.
    Piecoro LT; Wermeling DP; Schmitt FA; Ashford JW
    Pharmacotherapy; 1998; 18(5):1129-32. PubMed ID: 9758325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metrifonate.
    Lamb HM; Faulds D
    Drugs Aging; 1997 Dec; 11(6):490-6. PubMed ID: 9413706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.